A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

NCT06227910 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Vedolizumab
DRUG: Upadacitinib
DRUG: Placebo

Sponsor

Takeda